Top Back to top

Efficacy and Toxicity of ponatinib and 2nd generation TKI given after allogeneic SCT in Ph+ adult ALL.

Study number:
84210101
Short title:
TKI 2nd/mrd generation in Ph+ ALL
Study status:
Ongoing Data Collection
Deadline for data collection:
 
Study design:
 
Primary objective:
 
Key inclusion criteria:
 
Country:
 
Principal investigator:
Klaus HIRSCHBUEHL
Principal investigator email:
 
EBMT Study coordinator:
Mohamed HOUHOU
Study coordinator email:
mohamed.houhou@upmc.fr